» Articles » PMID: 1534821

Aqueous Antigens Induce in Vivo Tolerance Selectively in IL-2- and IFN-gamma-producing (Th1) Cells

Overview
Journal J Immunol
Date 1992 Jun 15
PMID 1534821
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

As a model for understanding in vivo immune responses, we have exposed mice to aqueous haptenated-protein Ag, and examined immune responses to subsequent immunization with Ag in adjuvant. Pretreating mice with soluble, TNP-conjugated Ag induces selective nonresponsiveness to Ag for both humoral and cell-mediated immune functions. Specific T cell proliferation in response to Ag is inhibited, and Ag-induced secretion of the lymphokines IL-2 and IFN-gamma, but not IL-4, is reduced. B cell responses after pretreatment are also affected. Although levels of TNP-specific IgG1 and IgE are similar in treated and untreated mice, soluble Ag pretreatment diminishes production of TNP-specific IgG2a and IgG2b. This is due to lack of T cell help and is not caused by tolerance in the B cell compartment. These results indicate that pretreatment of mice with aqueous Ag induces selective unresponsiveness in Th1-like Th cells, which secrete IL-2 and IFN-gamma, but not in Th2-like Th cells, which secrete IL-4.

Citing Articles

Th1 promotes M1 polarization of intestinal macrophages to regulate colitis-related mucosal barrier damage.

Ruan S, Xu L, Sheng Y, Wang J, Zhou X, Zhang C Aging (Albany NY). 2023; 15(14):6721-6735.

PMID: 37494667 PMC: 10415578. DOI: 10.18632/aging.204629.


PCSK6 mediates Th1 differentiation and promotes chronic colitis progression and mucosal barrier injury via STAT1.

Mei X, Zhou H, Song Z, Yang X, Liu X, Fei J Aging (Albany NY). 2023; 15(10):4363-4373.

PMID: 37211384 PMC: 10258034. DOI: 10.18632/aging.204739.


Immune Tolerance for Autoimmune Disease and Cell Transplantation.

Luo X, Miller S, Shea L Annu Rev Biomed Eng. 2016; 18:181-205.

PMID: 26928211 PMC: 4947009. DOI: 10.1146/annurev-bioeng-110315-020137.


Cellular and population plasticity of helper CD4(+) T cell responses.

Magombedze G, Reddy P, Eda S, Ganusov V Front Physiol. 2013; 4:206.

PMID: 23966946 PMC: 3744810. DOI: 10.3389/fphys.2013.00206.


Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.

Turley D, Miller S Results Probl Cell Differ. 2009; 51:217-35.

PMID: 19130025 PMC: 2901403. DOI: 10.1007/400_2008_13.